Outlook Therapeutics Inc (OTLK) has fallen Monday morning, with the stock losing -7.30% in pre-market trading to 8. OTLK's short-term technical score of 60 indicates that the stock has traded more bullishly over the last month than 60% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, the stock ranks higher than 72% of stocks. Outlook Therapeutics Inc has fallen 1.60% over the past month, closing at $8.96 on February 26. During this period of time, the stock fell as low as $5.73 and as high as $11.72. OTLK has an average analyst recommendation of Strong Buy. The company has an average price target of $37.67.
News Home
Outlook Therapeutics Inc has a Long-Term Technical rank of 41. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 59% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, OTLK ranks better than 71% of stocks.
Outlook Therapeutics Inc (OTLK) Down 7.30% in Premarket Trading
Mentioned in this article
OTLK has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on OTLK!